Squarepoint’s Aquestive Therapeutics AQST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.2K | Buy |
+26,034
| New | +$86.2K | ﹤0.01% | 2525 |
|
|
2024
Q4 | – | Sell |
-85,392
| Closed | -$425K | – | 2759 |
|
|
2024
Q3 | $425K | Buy |
85,392
+51,991
| +156% | +$259K | ﹤0.01% | 1839 |
|
|
2024
Q2 | $86.8K | Sell |
33,401
-5,845
| -15% | -$15.2K | ﹤0.01% | 2285 |
|
|
2024
Q1 | $167K | Buy |
+39,246
| New | +$167K | ﹤0.01% | 2142 |
|
|
2023
Q4 | – | Sell |
-75,683
| Closed | -$116K | – | 2487 |
|
|
2023
Q3 | $116K | Sell |
75,683
-47,824
| -39% | -$73.2K | ﹤0.01% | 2235 |
|
|
2023
Q2 | $204K | Buy |
123,507
+107,965
| +695% | +$178K | ﹤0.01% | 2073 |
|
|
2023
Q1 | $17.7K | Buy |
+15,542
| New | +$17.7K | ﹤0.01% | 2189 |
|
|
2021
Q3 | – | Sell |
-19,824
| Closed | -$79K | – | 2216 |
|
|
2021
Q2 | $79K | Buy |
+19,824
| New | +$79K | ﹤0.01% | 2456 |
|
|
2021
Q1 | – | Sell |
-42,797
| Closed | -$229K | – | 2537 |
|
|
2020
Q4 | $229K | Buy |
+42,797
| New | +$229K | ﹤0.01% | 2048 |
|
|
2020
Q3 | – | Sell |
-193,856
| Closed | -$942K | – | 2313 |
|
|
2020
Q2 | $942K | Buy |
193,856
+177,431
| +1,080% | +$862K | 0.02% | 974 |
|
|
2020
Q1 | $36K | Sell |
16,425
-2,225
| -12% | -$4.88K | ﹤0.01% | 1735 |
|
|
2019
Q4 | $109K | Sell |
18,650
-22,127
| -54% | -$129K | ﹤0.01% | 2237 |
|
|
2019
Q3 | $130K | Buy |
40,777
+2,587
| +7% | +$8.25K | ﹤0.01% | 2050 |
|
|
2019
Q2 | $160K | Buy |
38,190
+22,190
| +139% | +$93K | ﹤0.01% | 2079 |
|
|
2019
Q1 | $111K | Sell |
16,000
-13,828
| -46% | -$95.9K | ﹤0.01% | 1975 |
|
|
2018
Q4 | $188K | Buy |
+29,828
| New | +$188K | ﹤0.01% | 1689 |
|